Document is current

Article History

Received: 1 July 2022

Accepted: 11 July 2023

First Online: 18 September 2023

Declarations

:

: • The Clinical Research Committee of Organ Transplant Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia reviewed and approved the research proposal on 12/30/2021 with the control number: OTC-CRC-048.• The Research Ethics Committee of King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia reviewed the research proposal (RAC # 2221008) on 03/06/2022 and sent an approval letter on 04/04/2022.• The institutional review board (IRB) of Johns Hopkins University reviewed and approved the protocol, informed consent form(s), recruitment materials, and all participant materials (# JHU SOM IRB00250209) on 04/15/2022.• The IRB of King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia reviewed and approved the study protocol on 04/18/2022 (study # IRB 2022–18).• The Ethical Committee of Medic Medical Center in Ho Chi Minh, Ho Chi Minh City, Vietnam reviewed and approved the protocol on 06/10/2022.

: No identifiable images of participants and no patient details of individuals will be reported in the protocol and in the manuscripts arising out of this study. Hence, a consent for publication is not applicable.

: Dr Doan Y Dao and Dr Nam Nguyen Hai are affiliated with the Center of Excellence for Liver Disease in Vietnam, Johns Hopkins School of Medicine, which is the funding agency for this project.